US Leadership Summit


Like this article?

Sign up to our free newsletter

British Patient Capital commits USD20m to USD600m Balderton Capital VIII

British Patient Capital has made a USD20 million commitment into Balderton Capital VIII, which has closed at USD600 million.

The fund is Balderton’s largest ever early-stage fund and will look to invest in leading-edge technologies across the UK and Europe, building on the team’s expertise in backing companies from seed to growth stage. Portfolio companies from previous funds include fintech and insuretech unicorns Revolut and Zego, as well as AI technology companies Healx and Cleo, which have reached growth status since the initial investment.

This commitment follows British Patient Capital’s previous investments in Balderton Capital VI, Balderton Capital VII and, more recently, Balderton Capital Growth I, which closed in June 2021.

Like this article? Sign up to our free newsletter




Blackstone Private Equity

Talk to Us

What would you like to talk with us about? *